RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Their rabbit and goat monoclonal antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. After extensive screening and clone selection,
RevMAb antibodies are purified and recombinantly produced from an animal origin-free source.
Their team consists of pioneers in optimizing and transforming rabbit hybridoma technology for commercial application, and developing rabbit monoclonal antibodies for research, diagnostic and therapeutic use. With years of experience and strong expertise in antibody development,
RevMAb’s team of scientists aim to revolutionize antibody generation and develop high quality products in order to reveal true science.
RevMAb Biosciences is a part of
AdipoGen Life Sciences, who also cooperates with a number of other manufacturers such as:
AbFrontier,
Ancell Corporation,
BioActs,
BioViotica,
Chemodex,
Chimerigen Laboratories,
Innaxon,
JaICA,
South Bay Bio, and
SYNkinase.
Bio-Connect supplies all
RevMAb antibodies in the Benelux. If you have any questions, please contact the
helpdesk.
Major product lines
- Primary and secondary antibodies
For more information, please visit:
www.revmab.com
